Skip to search formSkip to main contentSkip to account menu

cinromide

Known as: 3-(3-bromophenyl)-N-ethyl-2-propenamide, 3-bromo-N-ethylcinnamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
A previous study of the metabolic fate of cinromide (3-bromo-N-ethylcinnamamide) in rhesus monkey established that half of a dose… 
1983
1983
Summary: Monotherapy with the experimental antiepileptic drug cinromide was evaluated in 11 adult outpatients with uncontrolled… 
1983
1983
Fifty percent of a cinromide dose was metabolized to an active metabolite in the rhesus monkey. The steady-state concentration of… 
1983
1983
Summary: The effect of the experimental anticonvulsant cinromide (3‐bromo‐N‐ethylcinnamamide) on various inhibitory and… 
1983
1983
Summary: Cinromide (BW‐122U) was evaluated in an open pilot study of absence seizures in three naive (previously untreated for… 
1983
1983
Summary: A double‐blind controlled trial of cinromide in 25 adult subjects with refractory epilepsy using the maximum tolerated… 
1983
1983
The dose-dependent nonlinearity of the clearance of cinromide, a medium extraction ratio drug, has been established in two… 
1981
1981
Christmas, A. J., Coulson, C. J., Maxwell, D. R., Riddell, Lees, A. J., Shaw, K. M., Kohout, L. J . , Stern, G. M., D. (1972) Br… 
1980
1980
Summary: In a previous study (Lockard et al., 1979) Cinromide (3 bromo‐N‐ethylcinnamamide), an experimental anticonvulsant… 
1979
1979
Summary: Cinromide (3 bromo‐N‐ethylcinnamamide), an experimental anticonvulsant (Burroughs‐Wellcome Pharmaceutical Co.), was…